ECE2017 Eposter Presentations: Diabetes, Obesity and Metabolism Diabetes (to include epidemiology, pathophysiology) (95 abstracts)
The prevalence of diabetic neuropathy, painful diabetic neuropathy and the at risk diabetic foot in Qatar
Tarik Elhadd 1 , Georgios Ponirakis 2 , Khaled Ashawesh 1 , Khaled Dukhan 1 , Adel Badie Abou Samra 1 & Rayaz Malik 1,
1Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar; 2Weil Cornell Medical College, Doha, Qatar.
Objective: To define the prevalence of Diabetic Peripheral Neuropathy (DPN), painful diabetic neuropathy (PDN) and the at risk diabetic foot in 2 out of the 3 National Diabetes Centres in Qatar.
Methods: 712 people with Type-1 & Type-2 diabetes recruited from Alwakra Hospital and Hamad General Hospital underwent assessment for DPN & PDN using the Neurothesiometer and the DN4 questionnaire, respectively.
Results: The average age, duration of diabetes, systolic BP, BMI, HbA1c were: 52.2±0.49, 10.8±0.32 years, 132.6±1.26 mmHg, 32.2±0.52 kg/m2 and 8.3±0.11%, respectively. The prevalence of DPN and PDN were 31% and 36%, respectively. However, 4 in 5 adults with DPN and 9 in 10 adults with PDN were undiagnosed. One in ten adults with diabetes were at high risk for diabetic foot ulceration (VPT >25) and had not been diagnosed. Patients with DPN were significantly older (57.1±0.73 v 49.8±0.62, P<0.0001), had a longer duration of diabetes (14.34±0.57 v 9.1±0.36, P<0.0001), higher systolic blood pressure (139.8±2.25 v 129.2±1.46, P=0.001) and higher creatinine (118.6±16.76 v 70.9±2, P=0.007), but no difference in HbA1c (8.6±0.21 v 8.2±0.13), vitamin D (23.7±1.7 v 23.3±0.9) or B12 (344.7±39.17 v 323±21.3).
Conclusion: The overall prevalence of DPN, PDN and those at risk of foot ulceration in Qatar are comparable to that reported in Europe and the US. However, an alarmingly low proportion of patients are diagnosed and treated for DPN and PDN. There is a need for a systematic screening for DPN and PDN in Qatar. Age, duration of diabetes, blood pressure and high creatinine are risk factors for DPN.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more